Government, Health News, ET HealthWorld

New Delhi: Sales of affordable quality generic drugs under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) amounted to Rs 814.21 crore in the current financial year, resulting in estimated savings of around Rs 4,800 crore citizens, Minister of Chemicals and Fertilizers Mansukh Mandaviya Rajya Sabha informed. In a statement laid on the table in the Upper House, the Union Minister said that the PMBJP was launched with the aim of making quality generic medicines accessible to all at affordable prices with dedicated outlets open for this purpose.

Under this program, till February 28, 2022, about 8,689 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJK) have been opened, covering all districts in the country, he added.

Emphasizing that Jan Aushadhi drugs are 50-90% cheaper than market prices of branded drugs, Mandaviya said, “During the current financial year (until February 28, 2022), total sales of Rs 814.21 crore has been realized, leading to estimated savings of around Rs 4,800 crore for citizens. »

In a written response to another question, the Minister said: “During the two years of the COVID-19 pandemic, the PMBJP achieved a sale of Rs 665.83 crore in the financial year 2020-21, this which saved around Rs. 4,000 crore to the citizens compared to branded drugs.”

The product basket of the PMBJP currently includes 1,616 drugs and 250 surgical items covering all major therapeutic groups such as cardiovascular, anti-cancer, anti-diabetic, anti-infective, anti-allergic, gastrointestinal and nutraceutical drugs, among others, a- he declared. in a response to another request.

The government’s effort is to improve the product basket of generic drugs and surgical products. This is an ongoing process based on feedback from various stakeholders and market demands, he added.

Responding to another question, Mandaviya said, “The government has set a target to have around 10,500 PMBJK by March 2025 nationwide. The goal for the year 2022-23 is to have around 9,300 PMBJK nationwide.


About Author

Comments are closed.